(MENAFN- EIN Presswire) EINPresswire/ -- The global Laboratory Information System (LIS) market is set for sustained expansion between 2025 and 2035 as healthcare providers continue to modernize diagnostic workflows and adopt digital platforms that enhance operational efficiency, data traceability, and patient care accuracy. The market, valued at approximately USD 2,281.1 million in 2025, is forecasted to reach USD 3,823.2 million by 2035, reflecting a CAGR of 5.3% over the decade.

This growth trajectory is driven by the rising volume of clinical testing, increasing adoption of automation within laboratories, and the need for robust systems that integrate seamlessly with electronic health records (EHR), diagnostic instrumentation, and analytics platforms. The shift toward personalized medicine and data-driven decision-making further underscores the need for LIS platforms capable of consolidating and managing complex patient data.

Explore trends before investing - request a sample report today!:-

Regional Momentum Driving Market Growth

North America, especially the United States, remains a leading market due to its advanced healthcare digital infrastructure, regulatory standards such as CLIA, and expanding use of laboratory automation. The U.S. LIS market alone is projected to achieve USD 1,496.8 million by 2035, supported by continued investment in high-throughput equipment and cloud-based workflow systems.

In Europe, particularly Germany and the United Kingdom, LIS adoption is expanding in response to increasing R&D activities and the rising complexity of laboratory workflows across clinical diagnostics and life sciences research. Strict compliance requirements and expanding healthcare digitalization initiatives further support adoption.

The Asia-Pacific (APAC) region is experiencing accelerated LIS market growth, driven by rising chronic disease burdens, expanding hospital networks, and national digital healthcare initiatives. Countries such as China, Japan, and South Korea are investing heavily in laboratory automation, data integration, and population-wide diagnostic modernization. China, in particular, is expected to grow at a double-digit CAGR through 2035.

Meanwhile, in the Middle East, Saudi Arabia is advancing LIS adoption through large-scale hospital digitization programs and government-led healthcare modernization aligned with Vision 2030. Investment in centralized diagnostic hubs and integrated care delivery models is contributing to sustained market traction.

Services and Cloud Deployment at the Forefront

By component, the services segment accounts for approximately 59.4% of the market in 2025, reflecting the importance of deployment support, integration, customization, and ongoing system optimization. Managed service offerings are increasingly sought by healthcare systems aiming to reduce IT complexity while maintaining compliance readiness and system uptime.

The cloud-based delivery model is gaining significant momentum and is projected to expand at a CAGR of 6.0% through 2035. Cloud LIS platforms support real-time accessibility, multi-location coordination, elastic scalability, and reduced capital expenditure compared to traditional on-premise systems. These features are particularly appealing to both decentralized point-of-care facilities and large integrated laboratory networks.

Clinics Emerging as Leading End Users

The clinics segment is anticipated to maintain its leadership with 44.5% market share in 2025, supported by the rising need for fast and accurate test results at the point of care. LIS platforms enhance diagnostic workflows, reduce manual errors, and support clinicians with timely access to integrated patient test data, promoting improved clinical outcomes.

Click Here to Purchase the Report:-

Competitive Landscape

Prominent market participants include Werfen, LabWare, Cerner Corporation, Xifin Inc., CompuGroup Medical, Epic Systems Corporation, Sysmex Corporation, LabVantage, and Medical Information Technology, Inc. Companies are investing in platform interoperability, AI-driven decision support, automation modules, and cloud-native architectures to strengthen competitive positioning.

Recent developments include:

.New LIS platform releases with integrated analytics dashboards and predictive insights.
.Strategic partnerships to advance remote diagnostics and data interoperability.
.Acquisitions aimed at expanding portfolio capabilities in population health and healthcare informatics.

Latest Healthcare IT Reports:-

Personal Emergency Response System (PERS) Market

Telehealth Kiosk Market

Mixed Reality Navigation Platforms Market

Why Choose FMI Empowering Decisions that Drive Real-World Outcomes:- s

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analystsworldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries:...
Website:
LinkedIn| Twitter| Blogs | YouTube

MENAFN07112025003118003196ID1110310458